Envestnet Asset Management Inc Vallon Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$1.79 - $8.0 $33,052 - $147,720	-18,465 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$4.02 - $7.3 $6,399 - $11,621	1,592 Added 9.44%	18,465 $110,000
Q3 2021 Oct 07, 2021	SELL	$3.85 - $9.68 $2,464 - $6,195	-640 Reduced 3.65%	16,873 $123,000
Q2 2021 Aug 04, 2021	BUY	$3.66 - $5.83 $20,997 - $33,446	5,737 Added 48.72%	17,513 $95,000
Q1 2021 May 04, 2021	BUY	$4.32 - $7.83 $50,872 - $92,206	11,776 New	11,776 $55,000

Ticker VLON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,512,800
Description
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.